Cargando…

Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels

INTRODUCTION: Behavioral sensitization is a phenomenon that develops from intermittent exposure to nicotine and other psychostimulants, which often leads to heightened locomotor activity and then relapse. Sulfonamides that act as carbonic anhydrase inhibitors have a documented role in enhancing dopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ur Rehman, Naeem, Abbas, Muzaffar, al-Rashida, Mariya, Tokhi, Ahmed, Arshid, Muhammad Awais, Khan, Muhammad Sona, Ahmad, Izhar, Rauf, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505708/
https://www.ncbi.nlm.nih.gov/pubmed/32982182
http://dx.doi.org/10.2147/DDDT.S270025
_version_ 1783584870701727744
author Ur Rehman, Naeem
Abbas, Muzaffar
al-Rashida, Mariya
Tokhi, Ahmed
Arshid, Muhammad Awais
Khan, Muhammad Sona
Ahmad, Izhar
Rauf, Khalid
author_facet Ur Rehman, Naeem
Abbas, Muzaffar
al-Rashida, Mariya
Tokhi, Ahmed
Arshid, Muhammad Awais
Khan, Muhammad Sona
Ahmad, Izhar
Rauf, Khalid
author_sort Ur Rehman, Naeem
collection PubMed
description INTRODUCTION: Behavioral sensitization is a phenomenon that develops from intermittent exposure to nicotine and other psychostimulants, which often leads to heightened locomotor activity and then relapse. Sulfonamides that act as carbonic anhydrase inhibitors have a documented role in enhancing dopaminergic tone and normalizing neuroplasticity by stabilizing glutamate release. OBJECTIVE: The aim of the current study was to explore synthetic sulfonamides derivative 4-fluoro-N-(4-sulfamoylbenzyl) benzene-sulfonamide (4-FBS) (with documented carbonic anhydrase inhibitory activity) on acquisition and expression of nicotine-induced behavioral sensitization. METHODS: In the acquisition phase, selected 5 groups of mice were exposed to saline or nicotine 0.5mg/kg intraperitoneal (i.p) for 7 consecutive days. Selected 3 groups were administered with 4-FBS 20, 40, and 60 mg/kg p.o. along with nicotine. After 3 days of the drug-free period, ie, day 11, a challenge dose of nicotine was injected to all groups except saline and locomotor activity was recorded for 30 minutes. In the expression phase, mice were exposed to saline and nicotine only 0.5 mg/kg i.p for 7 consecutive days. After 3 days of the drug-free period, ie, day 11, 4-FBS at 20, 40, and 60 mg/kg were administered to the selected groups, one hour after drug a nicotine challenge dose was administered, and locomotion was recorded. At the end of behavioral experiments, all animals were decapitated and the striatum was excised and screened for changes in adenosine levels, using HPLC-UV. RESULTS: Taken together, our findings showed that 4-FBS in all 3 doses, in both sets of experiments significantly attenuated nicotine-induced behavioral sensitization in mice. Additionally, 4-FBS at 60mg/kg significantly lowered the adenosine level in the striatum. CONCLUSION: The behavioral and adenosine modulation is promising, and more receptors level studies are warranted to explore the exact mechanism of action of 4-FBS.
format Online
Article
Text
id pubmed-7505708
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75057082020-09-24 Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels Ur Rehman, Naeem Abbas, Muzaffar al-Rashida, Mariya Tokhi, Ahmed Arshid, Muhammad Awais Khan, Muhammad Sona Ahmad, Izhar Rauf, Khalid Drug Des Devel Ther Original Research INTRODUCTION: Behavioral sensitization is a phenomenon that develops from intermittent exposure to nicotine and other psychostimulants, which often leads to heightened locomotor activity and then relapse. Sulfonamides that act as carbonic anhydrase inhibitors have a documented role in enhancing dopaminergic tone and normalizing neuroplasticity by stabilizing glutamate release. OBJECTIVE: The aim of the current study was to explore synthetic sulfonamides derivative 4-fluoro-N-(4-sulfamoylbenzyl) benzene-sulfonamide (4-FBS) (with documented carbonic anhydrase inhibitory activity) on acquisition and expression of nicotine-induced behavioral sensitization. METHODS: In the acquisition phase, selected 5 groups of mice were exposed to saline or nicotine 0.5mg/kg intraperitoneal (i.p) for 7 consecutive days. Selected 3 groups were administered with 4-FBS 20, 40, and 60 mg/kg p.o. along with nicotine. After 3 days of the drug-free period, ie, day 11, a challenge dose of nicotine was injected to all groups except saline and locomotor activity was recorded for 30 minutes. In the expression phase, mice were exposed to saline and nicotine only 0.5 mg/kg i.p for 7 consecutive days. After 3 days of the drug-free period, ie, day 11, 4-FBS at 20, 40, and 60 mg/kg were administered to the selected groups, one hour after drug a nicotine challenge dose was administered, and locomotion was recorded. At the end of behavioral experiments, all animals were decapitated and the striatum was excised and screened for changes in adenosine levels, using HPLC-UV. RESULTS: Taken together, our findings showed that 4-FBS in all 3 doses, in both sets of experiments significantly attenuated nicotine-induced behavioral sensitization in mice. Additionally, 4-FBS at 60mg/kg significantly lowered the adenosine level in the striatum. CONCLUSION: The behavioral and adenosine modulation is promising, and more receptors level studies are warranted to explore the exact mechanism of action of 4-FBS. Dove 2020-09-17 /pmc/articles/PMC7505708/ /pubmed/32982182 http://dx.doi.org/10.2147/DDDT.S270025 Text en © 2020 Ur Rehman et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ur Rehman, Naeem
Abbas, Muzaffar
al-Rashida, Mariya
Tokhi, Ahmed
Arshid, Muhammad Awais
Khan, Muhammad Sona
Ahmad, Izhar
Rauf, Khalid
Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title_full Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title_fullStr Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title_full_unstemmed Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title_short Effect of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide on Acquisition and Expression of Nicotine-Induced Behavioral Sensitization and Striatal Adenosine Levels
title_sort effect of 4-fluoro-n-(4-sulfamoylbenzyl) benzene sulfonamide on acquisition and expression of nicotine-induced behavioral sensitization and striatal adenosine levels
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505708/
https://www.ncbi.nlm.nih.gov/pubmed/32982182
http://dx.doi.org/10.2147/DDDT.S270025
work_keys_str_mv AT urrehmannaeem effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT abbasmuzaffar effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT alrashidamariya effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT tokhiahmed effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT arshidmuhammadawais effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT khanmuhammadsona effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT ahmadizhar effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels
AT raufkhalid effectof4fluoron4sulfamoylbenzylbenzenesulfonamideonacquisitionandexpressionofnicotineinducedbehavioralsensitizationandstriataladenosinelevels